TY - JOUR
T1 - A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications
AU - Buckley, Patrick G.
AU - Mantripragada, Kiran K.
AU - Benetkiewicz, Magdalena
AU - Tapia-Páez, Isabel
AU - Diaz de Ståhl, Teresita
AU - Rosenquist, Magnus
AU - Ali, Haider
AU - Jarbo, Caroline
AU - de Bustos, Cecilía
AU - Hirvelä, Carina
AU - Wilén, Birgitta Sinder
AU - Fransson, Ingegerd
AU - Thyr, Charlotte
AU - Johnsson, Britt Inger
AU - Bruder, Carl E.G.
AU - Menzel, Uwe
AU - Hergersberg, Martin
AU - Mandahl, Nils
AU - Blennow, Elisabeth
AU - Wedell, Anna
AU - Beare, David M.
AU - Collins, John E.
AU - Dunham, Ian
AU - Albertson, Donna
AU - Pinkel, Daniel
AU - Bastian, Boris C.
AU - Faruqi, A. Fawad
AU - Lasken, Roger S.
AU - Ichimura, Koichi
AU - Collins, V. Peter
AU - Dumanski, Jan P.
N1 - Funding Information:
We thank Dr Bruce A Roe and the staff of the Advanced Center for Genome Technology, University of Oklahoma, for providing chromosome 22 genomic clones. We would also like to thank Drs Rolf Ohlsson, Ulf Landegren, Maria Kost-Alimova, Stephan Imreh, Ulf G. Pettersson, Kenneth Nilsson, Monika Nister and Göran Levan for critical review of the manuscript. This work was supported by grants from the U.S. Army Medical Research and Materiel Command, award no. DAMD17-00-1-0536, the Swedish Cancer Foundation, the Swedish Research Council and Uppsala University to J.P.D. C.D.B is supported by a fellowship from the Department of Education, Universities and Research of the Basque Government for the formation of researchers. I.D., J.E.C. and D.M.B. are supported by the Wellcome Trust.
PY - 2002/12/1
Y1 - 2002/12/1
N2 - We have constructed the first comprehensive microarray representing a human chromosome for analysis of DNA copy number variation. This chromosome 22 array covers 34.7 Mb, representing 1.1 % of the genome, with an average resolution of 75 kb. To demonstrate the utility of the array, we have applied it to profile acral melanoma, dermatofibrosarcoma, DiGeorge syndrome and neurofibromatosis 2. We accurately diagnosed homozygous/heterozygous deletions, amplifications/gains, IGLV/IGLC locus instability, and breakpoints of an imbalanced translocation. We further identified the 14-3-3 eta isoform as a candidate tumor suppressor in glioblastoma. Two significant methodological advances in array construction were also developed and validated. These include a strictly sequence defined, repeat-free, and non-redundant strategy for array preparation. This approach allows an increase in array resolution and analysis of any locus; disregarding common repeats, genomic clone availability and sequence redundancy. In addition, we report that the application of phi29 DNA polymerase is advantageous in microarray preparation. A broad spectrum of issues in medical research and diagnostics can be approached using the array. This well annotated and gene-rich autosome contains numerous uncharacterized disease genes. It is therefore crucial to associate these genes to specific 22q-related conditions and this array will be instrumental towards this goal. Furthermore, comprehensive epigenetic profiling of 22q-located genes and high-resolution analysis of replication timing across the entire chromosome can be studied using our array.
AB - We have constructed the first comprehensive microarray representing a human chromosome for analysis of DNA copy number variation. This chromosome 22 array covers 34.7 Mb, representing 1.1 % of the genome, with an average resolution of 75 kb. To demonstrate the utility of the array, we have applied it to profile acral melanoma, dermatofibrosarcoma, DiGeorge syndrome and neurofibromatosis 2. We accurately diagnosed homozygous/heterozygous deletions, amplifications/gains, IGLV/IGLC locus instability, and breakpoints of an imbalanced translocation. We further identified the 14-3-3 eta isoform as a candidate tumor suppressor in glioblastoma. Two significant methodological advances in array construction were also developed and validated. These include a strictly sequence defined, repeat-free, and non-redundant strategy for array preparation. This approach allows an increase in array resolution and analysis of any locus; disregarding common repeats, genomic clone availability and sequence redundancy. In addition, we report that the application of phi29 DNA polymerase is advantageous in microarray preparation. A broad spectrum of issues in medical research and diagnostics can be approached using the array. This well annotated and gene-rich autosome contains numerous uncharacterized disease genes. It is therefore crucial to associate these genes to specific 22q-related conditions and this array will be instrumental towards this goal. Furthermore, comprehensive epigenetic profiling of 22q-located genes and high-resolution analysis of replication timing across the entire chromosome can be studied using our array.
UR - http://www.scopus.com/inward/record.url?scp=18144445946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18144445946&partnerID=8YFLogxK
U2 - 10.1093/hmg/11.25.3221
DO - 10.1093/hmg/11.25.3221
M3 - Review article
C2 - 12444106
AN - SCOPUS:18144445946
SN - 0964-6906
VL - 11
SP - 3221
EP - 3229
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 25
ER -